These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 344230)

  • 21. Neutrophil-derived eosinophil chemotactic factor production induced by immune complexes.
    Czarnetzki BM; Schulz W
    Int Arch Allergy Appl Immunol; 1981; 64(1):51-9. PubMed ID: 6778829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
    Martin TR; Raugi G; Merritt TL; Henderson WR
    J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema.
    Czarnetzki BM; Kalveram KJ; Dierksmeier U
    J Invest Dermatol; 1979 Aug; 73(2):163-5. PubMed ID: 156767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes.
    Czarnetzki BM; König W; Lichtenstein LM
    Inflammation; 1976 Mar; 1(2):201-15. PubMed ID: 24194429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophil chemotactic factor released from murine bone marrow derived cultured mast cells.
    Abe T; Nawa Y
    Arerugi; 1990 Feb; 39(2 Pt 1):69-74. PubMed ID: 2141250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Wasserman SI; Whitmer D; Geotzl EJ; Austen KF
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):301-6. PubMed ID: 1129271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of eosinophil chemotaxis and eosinophil chemotactic factor release by concanavalin A.
    Czarnetzki BM; König W
    Int Arch Allergy Appl Immunol; 1978; 56(6):551-7. PubMed ID: 631923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An eosinophil leukocyte chemotactic factor of anaphylaxis.
    Kay AB; Stechschulte DJ; Austen KF
    J Exp Med; 1971 Mar; 133(3):602-19. PubMed ID: 4106805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose.
    Fischer N; Czarnetzki BM
    J Invest Dermatol; 1982 Oct; 79(4):222-6. PubMed ID: 7130738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD; Lee TH; Lewis RA; Austen F
    J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The production of macrophage inflammatory protein-1 alpha by human basophils.
    Li H; Sim TC; Grant JA; Alam R
    J Immunol; 1996 Aug; 157(3):1207-12. PubMed ID: 8757627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Type IV allergic reaction (delayed type)].
    Hirashima M
    Nihon Rinsho; 1993 Mar; 51(3):669-74. PubMed ID: 8492441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187.
    Dessein AJ; Lee TH; Elsas P; Ravalese J; Silberstein D; David JR; Austen KF; Lewis RA
    J Immunol; 1986 May; 136(10):3829-38. PubMed ID: 3009610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore.
    Braun RK; Franchini M; Erard F; Rihs S; De Vries IJ; Blaser K; Hansel TT; Walker C
    Eur J Immunol; 1993 Apr; 23(4):956-60. PubMed ID: 8458381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.
    Capron M; Capron A; Goetzl EJ; Austen KF
    Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil chemotactic activity released in supernatants of human leukocytes challenged with antigens or anti-human IgE.
    Akiyama K; Pruzansky JJ; Ricketti AJ; Greenberger PA; Patterson R
    J Lab Clin Med; 1984 Sep; 104(3):391-403. PubMed ID: 6470565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of eosinophilic leukocytes in inflammatory dermatoses].
    Czarnetzki BM
    Hautarzt; 1980 Jun; 31(6):291-6. PubMed ID: 6997234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.